Delphia (USA)’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,587
Closed -$202K 133
2023
Q2
$202K Buy
+10,587
New +$189K 0.32% 161
2023
Q1
Sell
-11,298
Closed -$221K 316
2022
Q4
$221K Buy
+11,298
New +$220K 0.25% 176
2022
Q3
Sell
-7,538
Closed -$237K 382
2022
Q2
$237K Buy
7,538
+1,375
+22% +$49.8K 0.16% 238
2022
Q1
$271K Buy
6,163
+469
+8% +$20.1K 0.2% 188
2021
Q4
$248K Buy
+5,694
New +$223K 0.26% 157

Other funds holding ACH

Delphia (USA)'s ACH Position: Q3 2023 in Review

Delphia (USA) sold out of Accendra Health (ACH) in Q3 2023, closing a stake of 10,587 shares — an estimated $202K sold.

Delphia (USA) first reported a position in ACH in Q4 2021 and held it in 5 quarters. The position peaked at $271K in Q1 2022. 211 funds tracked by Wall St. Rank hold ACH as of Q3 2023.

  • Delphia (USA) reported no remaining Accendra Health position as of Q3 2023 after selling out during the quarter.
  • Delphia (USA) sold 10,587 Accendra Health shares in Q3 2023, an estimated $202K.
  • Delphia (USA) first reported a position in Accendra Health in Q4 2021 and held it in 5 quarters.
  • Delphia (USA)'s Accendra Health position peaked at $271K in Q1 2022.
  • 211 funds tracked by Wall St. Rank held Accendra Health as of Q3 2023.

Based on Delphia (USA)'s 13F filing for Q3 2023, filed 15 Nov 2023.